Neutrophil-progenitor feedback sustains splenic myelopoiesis and promotes immune evasion in cancer
Journal of Clinical Investigation · 16.11.2026 · 136 (22)
DOI: 10.1172/jci204067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 29.09.2026. Verfasst von Lan Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Pharmaceutical Functional Genes, MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, …. Hauptthemen laut MEDLINE: Neutrophils, Myelopoiesis, Spleen, Hematopoietic Stem Cells. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Key-Area Research and Development Program of Guangdong Province.
Abstract (Originalsprache)
Splenic myelopoiesis supplies immunosuppressive myeloid cells in cancer, yet its local regulation remains unclear. Here, we identify a self-amplifying circuit between neutrophils and hematopoietic stem and progenitor cells (HSPCs) that sustains splenic myelopoiesis. Tumor-associated neutrophils produced ROS and created an oxidatively stressed milieu in the spleen, which activated FOXO1 in neighboring HSPCs and drove dynamin-related protein 1 (DRP1)-mediated mitochondrial fission, reprogramming HSPCs toward myeloid-biased expansion and immunosuppressive output. Progeny neutrophils reinforced splenic oxidative stress and perpetuated this loop. Genetic ablation of cytochrome b-245, beta polypeptide ( Cybb ) or spleen-targeted ROS scavenging inhibited FOXO1 activation and preserved fused mitochondrial morphology in HSPCs. Consistently, blockade of FOXO1 or DRP1 prevented mitochondrial fission and reduced ROS-producing myeloid cell generation. Such interventions reduced splenic myelopoiesis, curtailed the production of suppressive myeloid cells in the spleen and their infiltration into tumors, and enhanced cytotoxic T cell activity, thereby restoring antitumor immunity and restraining tumor progression. Analyses of spleen samples from patients with cancer, together with CB HSPC and neutrophil coculture experiments, support the human relevance of this neutrophil/ROS/HSPC axis. These findings reveal a self-propagating neutrophil-HSPC feedback circuit that locally sustains tumor-promoting splenic myelopoiesis and provide a rationale for targeting neutrophil-to-progenitor signaling to normalize antitumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Pharmaceutical Functional Genes, MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
- Hunan Key Laboratory of Molecular Radiation Oncology, Xiangya Cancer Center, Central South University, Changsha, China.
- Department of Gastrointestinal Surgery, Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Key-Area Research and Development Program of Guangdong Province
- Open Fund Project of Guangdong Academy of Medical Sciences
- Science and Technology Planning Project of Guangdong Province
Zitieren
APA
Zhu, L., Luo, S., Hua, Q., Zhao, C. A., Lin, H., Liu, M., Zhu, L., Zheng, J., Feng, H., Li, Y., Wu, C., & Zheng, L. (2026). Neutrophil-progenitor feedback sustains splenic myelopoiesis and promotes immune evasion in cancer. Journal of Clinical Investigation, 136(22). https://doi.org/10.1172/jci204067
Vancouver
Zhu L, Luo S, Hua Q, Zhao CA, Lin H, Liu M, et al. Neutrophil-progenitor feedback sustains splenic myelopoiesis and promotes immune evasion in cancer. Journal of Clinical Investigation. 2026;136(22). doi:10.1172/jci204067
BibTeX
@article{Zhu2026,
author = {Zhu, Lan and Luo, Shufeng and Hua, Qiaomin and Zhao, Chang-An and Lin, Huiling and Liu, Mingyu and Zhu, Lingyan and Zheng, Jiabin and Feng, Huolun and Li, Yong and Wu, Chong and Zheng, Limin},
title = {Neutrophil-progenitor feedback sustains splenic myelopoiesis and promotes immune evasion in cancer},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {22},
doi = {10.1172/jci204067}
}
EUVIMED